Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncotelic Therapeutics Inc
(OP:
OTLC
)
0.0207
+0.0002 (+0.98%)
Streaming Delayed Price
Updated: 2:38 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Oncotelic Therapeutics Inc
Oncotelic Publishes SNO 27th Annual Meeting Presentation Materials
November 30, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Oncotelic Reports Q3 2022 Compared to Q3 2021 Financial Results
November 21, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Oncotelic Publishes SITC Meeting 2022 Presentation Materials
November 16, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Oncotelic Initiates Clinical Trials Evaluating OT-101 against Pediatric Gliomas
November 08, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Oncotelic Awarded BARDA Funding for Development of OT-101 for long COVID
October 12, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Oncotelic Announces Formation of Animal Health Division
October 06, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Oncotelic Presenting Data for OT101 Against Pancreatic Cancer (PDAC) at the SITC 37th Annual Meeting
September 28, 2022
From
Oncotelic Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.